These are some of the top analyst upgrades, downgrades and initiations seen from Wall St. research calls this Tuesday.
Automatic Data Processing Inc. (NASDAQ: ADP) cut to Neutral at UBS.
Bank of New York Mellon Corp. (NYSE: BK) started as Buy at Citigroup.
Buffalo Wild Wings Inc. (NASDAQ: BWLD) raised to Outperform at RBC.
General Electric Co. (NYSE: GE) reiterated Buy with $25 target at BofA/ML.
Genomic Health Inc. (NASDAQ: GHDX) started as Outperform at Credit Suisse.
Life Technologies Corp. (NASDAQ: LIFE) started as Outperform at William Blair.
Myriad Genetics Inc. (NASDAQ: MYGN) started as Neutral at Credit Suisse.
Nike Inc. (NYSE: NKE) reiterated Buy with $120 target at BofA/ML.
Nokia Corp. (NYSE: NOK) cut to Underperform at BMO.
Northern Trust Corp. (NASDAQ: NTRS) started as Neutral at Citigroup.
Pandora Media Inc. (NYSE: P) started as Reduce at Nomura.
Paychex Inc. (NASDAQ: PAYX) cut to Sell at Citigroup.
Red Hat Inc. (NYSE: RHT) reiterated Buy with $61 target at BofA/ML.
Questcor Pharmaceuticals Inc. (NASDAQ: QCOR) removed from Focus List but maintained Buy at BofA/ML.
Sequenom Inc. (NASDAQ: SQNM) started as Underperform at Credit Suisse.
State Street Corp. (NYSE: STT) started as Buy at Citigroup.
TiVo Inc. (NASDAQ: TIVO) raised to Buy at Lazard.
Total S.A. (NYSE: TOT) maintained Underperform at BofA/ML.
Walgreen Co. (NYSE: WAG) put on the Conviction Buy List with $43 target at Goldman Sachs.
JON C. OGG